Background

• A lack of evidence-based recommendations regarding the timing of administration of immunomodulary medications with respect to COVID-19 vaccination led to inconsistent provider recommendations and patient confusion.
• In rheumatology, the American College of Rheumatology (ACR) published guidelines 1 to standardize recommendations and to ensure medication adherence and optimal immune response to the COVID-19 vaccine. Guidance varied based on drug class, perpetuating confusion on whether to administer or not administer medication.
• Health system specialty pharmacists are in a unique position to provide appropriate education and manage medication adherence in this patient population.

Objectives

• The primary objective is to determine the impact of pharmacist education on patient alignment with ACR guidelines regarding appropriateness of biologic DMARD dosing with respect to COVID-19 vaccination.
• The secondary objective is to measure pharmacist impact on COVID-19 vaccination rates.

Read about the team's findings by downloading the Outcomes Study below.

Download the abstract: